Skip to main content
Caplight Logo









Evasc Neurovascular

Evasc Neurovascular

Private
VancouverHealthcare & Life Scienceshttps://www.evasc.com/

Last Round

Grant

Feb 23, 2021

Total Funding Raised

$10.84M

Company Overview

Evasc Neurovascular is a medical device company that develops endovascular treatment systems for cerebral aneurysms.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurovascular deviceflow-diverting stentintracranial aneurysmeCLIPsneuro-interventional deviceaneurysm treatmentbifurcation aneurysmendovascular implantflow diverterneurovascular interventionmedical deviceneuro-interventional radiologystentneuro-interventioninterventional neuroradiology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evasc Neurovascular Comparables

Compare Evasc Neurovascular with similar companies based on industry and business-model similarity.

Evasc Neurovascular comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Acandis
89%
Wallaby Medical
82%
Terumo Corporation
79%

Evasc Neurovascular Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 23, 2021
Series AJun 15, 2017

Key People

Founding team and executive leadership

Donald R. Ricci

Interim CEO

Executive Team

Scott Wilson

CFO COO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Monthly visitors increased 90% MoM.

  • May 2, 2025

    Monthly visitors increased 141% MoM, reaching 1.4K.

Evasc Neurovascular Filings

Explore SEC and related filing metadata, where available.

Evasc Neurovascular filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Evasc Neurovascular's valuation, stock price, and market status.

Is Evasc Neurovascular a public or private company?

Evasc Neurovascular is a private company.

What is the current stock price of Evasc Neurovascular?

Evasc Neurovascular is a private company with no public stock price. No recent secondary market data is available.

How much is Evasc Neurovascular worth (valuation)?

Valuation information for Evasc Neurovascular is not publicly available.

Can I buy Evasc Neurovascular stock?

Evasc Neurovascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Evasc Neurovascular's last funding round?

Funding round information for Evasc Neurovascular is not publicly available.

Who are the main investors in Evasc Neurovascular?

Investor information for Evasc Neurovascular is not publicly disclosed.

Will Evasc Neurovascular IPO soon?

No public IPO plans have been announced for Evasc Neurovascular.

How can I track Evasc Neurovascular secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evasc Neurovascular's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVancouver
Employee Range18
Year Founded2001
Last FundingFeb 23, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?